1. Home
  2. Analysis
  3. Synribo
  4. Claritin

Synribo and Claritin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Synribo (omacetaxine mepesuccinate) and Claritin (loratadine). Common drug interactions include anaemia among females and hospitalisation among males.

The phase IV clinical study analyzes what interactions people have when they take Synribo and Claritin. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Synribo?

Synribo has active ingredients of omacetaxine mepesuccinate. eHealthMe is studying from 799 Synribo users. Check the latest studies of Synribo.

What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,315 Claritin users. Check the latest studies of Claritin.

On Jul, 12, 2026

14 people who take Synribo and Claritin together, and have interactions are studied.

Synribo and Claritin drug interactions.

What are the common drug interactions of Synribo and Claritin, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Blindness
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Death
  5. Feeling cold
  6. Full blood count increased
  7. Hospitalisation
  8. Injection site erythema (redness at injection site)
  9. Injection site rash
  10. Nausea (feeling of having an urge to vomit)

male:

  1. Hospitalisation
  2. Death
  3. Injection site erythema (redness at injection site)
  4. Pneumonia
  5. Rhinorrhoea (watery mucus discharge from the nose)

What are the common drug interactions of Synribo and Claritin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Full blood count increased

60+:

  1. Blood iron decreased
  2. Diarrhoea
  3. Pyrexia (fever)
  4. Rhinorrhoea (watery mucus discharge from the nose)
  5. Visual impairment
  6. Hospitalisation
  7. Anaemia (lack of blood)
  8. Blindness
  9. Death
  10. Feeling cold

What are the existing conditions these people have? *

  1. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 10 people, 71.43%
  2. Anaemia (lack of blood): 4 people, 28.57%
  3. Neoplasm Malignant (cancer tumour): 3 people, 21.43%
  4. Stable Angina (a constant chest pain): 1 person, 7.14%
  5. Seasonal Allergy (allergic condition due to certain season): 1 person, 7.14%
  6. High Blood Pressure: 1 person, 7.14%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.14%
  8. Cardiac Disorder: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Synribo and Claritin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Synribo and Claritin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Synribo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Claritin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Synribo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Claritin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on omacetaxine mepesuccinate and loratadine (the active ingredients of Synribo and Claritin, respectively), and Synribo and Claritin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.